Vancouver, BC, September 10, 2021 – Solarvest Bioenergy Inc. (“Solarvest” or the “Company”) (TSX-V:SVS) held its annual general meeting of shareholders (the “Meeting”) on Wednesday, September 8. A total of 19,294,920 common shares (representing 34.87% of all issued and outstanding common shares of the Company) were represented at the Meeting. Shareholders of the Company (the “Shareholders”) voted in favor of all items of business put forth at the Meeting.
- The number of Directors for the Company was set at three (3).
- The three members elected to the Board of Directors include: Gerri Greenham, William Cheliak and Gregory Drohan.
- ArsenaultBestCameronEllis, Chartered Accountants, was re-appointed as auditor of the Company for the ensuing year.
- The Company’s Stock Option Plan was approved and ratified.
Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has successfully developed, patented and produced the world’s only plant-based organic certified Omega -3 to satisfy the substantial demand for this essential nutrient. The
company has also initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.
For further information contact:
The TSX Venture Exchange has neither approved nor disapproved the contents of this news release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company’s expectations and projections.